Literature DB >> 17410001

Small randomized trials.

Mary Redman, John Crowley.   

Abstract

Mesh：

Year:  2007        PMID： 17410001     DOI： 10.1097/JTO.0b013e31802c8d84

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  7 in total

1.  To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.

Authors:  Alyssa M Vanderbeek; Steffen Ventz; Rifaquat Rahman; Geoffrey Fell; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

Review 2.  Randomized phase II designs.

Authors:  Larry Rubinstein; John Crowley; Percy Ivy; Michael Leblanc; Dan Sargent
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

3.  Current issues in oncology drug development, with a focus on Phase II trials.

Authors:  Daniel J Sargent; Jeremy M G Taylor
Journal:  J Biopharm Stat       Date:  2009       Impact factor: 1.051

4.  Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.

Authors:  Mary W Redman; Bryan H Goldman; Michael LeBlanc; Anne Schott; Laurence H Baker
Journal:  Clin Cancer Res       Date:  2013-05-15       Impact factor: 12.531

Review 5.  Designing phase II trials in cancer: a systematic review and guidance.

Authors:  S R Brown; W M Gregory; C J Twelves; M Buyse; F Collinson; M Parmar; M T Seymour; J M Brown
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

Review 6.  A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials.

Authors:  Michael J Grayling; Munyaradzi Dimairo; Adrian P Mander; Thomas F Jaki
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

7.  A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.

Authors:  Daniel D Von Hoff; Gary M Clark; Charles A Coltman; Mary L Disis; S G Eckhardt; Lee M Ellis; Margaret Foti; Elizabeth Garrett-Mayer; Mithat Gönen; Manuel Hidalgo; Susan G Hilsenbeck; John H Littlefield; Patricia M LoRusso; H Kim Lyerly; Neal J Meropol; Jyoti D Patel; Steven Piantadosi; Dean A Post; Meredith M Regan; Yu Shyr; Margaret A Tempero; Joel E Tepper; Jamie Von Roenn; Louis M Weiner; Donn C Young; Nu V Vu
Journal:  Clin Cancer Res       Date:  2021-07-26       Impact factor: 12.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.